Lv5
804 积分 2021-08-19 加入
Beyond PI3Ks: targeting phosphoinositide kinases in disease
9小时前
待确认
mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA -Mutant Breast Cancer
19天前
已完结
Abstract 3794: ACR246, a first-in-class 5T4 antibody-drug conjugate (ADC), showed promising anticancer efficacy in preclinical models and patient with esophageal cancer
27天前
已完结
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
1个月前
已完结
Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma
1个月前
已完结
STX-478, RLY-2608, and LOXO-783: third-generation PIK3CA mutant-selective allosteric inhibitors
2个月前
已完结
Immortalized keratinocytes cells generates an effective model of Epidermal Human Equivalent for irritation and corrosion tests
3个月前
已完结
AKT/PKB Signaling: Navigating the Network
3个月前
已完结
First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis
4个月前
已完结
KRAS combination strategies: How well aligned is clinical and preclinical research?
4个月前
已完结
皖公网安备34019202002308
